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Burkholderia pseudomallei is an infectious bacterium, which causes a lethal 
disease, melioidosis, and has potential for misuse as a bioweapon. The cell wall of this 
bacterium contains lipopolysaccharides (LPSs). A component of LPS is a phosphorylated 
glycolipid known as lipid A, which may be responsible for pathogenic properties of B. 
pseudomallei. Therefore, the studies about the structure of lipid A and the influence of 
lipid A on the virality of B. pseudomallei are important.    
Here, lipid A species originating from B. pseudomallei strain 1026b and avirulent 
B. thailandensis strain E264 were structurally characterized by mass spectrometry (MS) 
and their lipid A profiles were compared as well. An earlier study by Novem et al. on 
lipid A from B. pseudomallei strain KHW and B. thailandensis strain ATCC 700388 
revealed that a lipid A species with a mass-to-charge ratio (m/z) of 973.59 (z=-2) was 
different between the two bacteria, and a hypothetical structure of this B. pseudomallei-
specific ion was proposed. In order to further investigate the structural differences of lipid 
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A between B. pseudomallei and B. thailandensis, MALDI-MS and ESI-MS were used in 
this study.  
The lipid A samples were isolated from B. pseudomallei 1026b and B. 
thailandensis E264 using a hot phenol-water extraction protocol. After liquid-liquid 
extraction into a chloroform/methanol phase, lipid A species were analyzed by MALDI-
MS (using mostly 6-aza-2-thiothymine (ATT) as the matrix) and ESI-MS in negative ion 
mode, while tandem mass spectrometry (MS/MS) was used for structural investigation of 
lipid A ions. Additionally, partial and complete O-deacylation of lipid A samples were 
achieved using ammonium hydroxide and methylamine solutions, respectively, in order 
to study structures of lipid A acyl chains.  
MALDI-MS of lipid A from B. pseudomallei 1026b and B. thailandensis E264 
confirmed that an ion with an m/z value of 1580.040 (z=-1) was detected only in B. 
pseudomallei 1026b. Since deprotonated lipid A corresponding to this m/z was not found 
in the literature and available lipid structure databases, the structure of this and other 
deprotonated lipid A species were studied further using MALDI and ESI-MS/MS.  
In the MALDI-MS/MS data of the lipid A ion with an m/z value of 1580.040, a 
peak at m/z value of 1444.023 was detected that was also seen in a MALDI-MS spectrum 
of a lipid A sample from B. pseudomallei 1026b. Based on this, it was hypothesized that 
the lipid A ion with an m/z of 1580.040 could be a structural modification of 136 mass 
units on the lipid A structure of the ion with an m/z of 1444.023. Two parent structures 
were proposed for the lipid A ion with an m/z value of 1580.040. However, the possibility 
of having different structural isomers makes it difficult to propose, or to confirm, an exact 
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parent structure of the lipid A ion with an m/z of 1580.040. Additionally, the presence of 
phosphorylated species with m/z values of ~79 (PO3-) and 97 (H2PO4-) and 
pyrophosphorylated species with m/z values of ~ 159 (HP2O6-) and 176 (H3P2O7-) 
indicated that this lipid A structure likely contains two phosphoryl residues. 
To further study the structures of lipid A species from B. pseudomallei 1026b, 
partial and complete O-deacylation of lipid A samples were performed. MALDI-MS 
spectra obtained after partial O-deacylation of lipid A samples showed intense ions with 
m/z values of 1137.712 and 1217.639, while peaks at 927.591 and 1007.548 were 
detected after complete O-deacylation. MALDI-MS/MS studies of O-deacylated lipid A 
revealed the identity of the O-acyl chains in B. pseudomallei lipid A that were proposed 
previously by Novem et al. The structures of these species also show the presence of C16:0 
acyl chains attached to the sugar moieties by an amide linkage at positions 2 and 2´ of the 
two glucosamines.  
In summary, a lipid A ion with an m/z of 1580.040, which is unique to B. 
pseudomallei 1026b, was detected and structurally characterized by MALDI and ESI-MS 
analysis in this study. This lipid A is likely a biphosphorylated glycolipid containing five 
acyl chains attached to two glucosamines. However, an exact structure of this glycolipid 
and its potential influence on the virulence of B. pseudomallei 1026b remains to be 
determined in future studies.  
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Chapter 1 
Introduction 
 
	  	  
1.1 Burkholderia pseudomallei and Burkholderia thailandensis, Gram-negative      
      Bacteria 
 Burkholderia pseudomallei is an infectious Gram-negative bacterium, which 
causes the lethal disease melioidosis, and has potential for misuse as a bioweapon.1 B. 
pseudomallei is commonly found in the soil and water across Southeast Asia and 
Northern Australia. Symptoms of melioidosis include chronic abscesses and acute 
septicemia.2 Several studies have been performed on melioidosis patients to prove that 
this disease is non-contagious. It is only spread by inhalation and ingestion of bacterium 
or by skin inoculation.3 Additional research has been devoted to the analysis of structural 
and functional relationships between B. pseudomallei and genetically similar, but aviral 
species such as Burkholderia thailandensis.1, 4 
Due to the ability of bacterial lipopolysaccharides (LPSs) to induce an immune 
response in a host organism, the structural analysis of LPSs found in the B. pseudomallei  
cell wall is important.5 Typically, an LPS has three domains: a hydrophilic 
polysaccharide chain (O-antigen), the intermediate core oligosaccharide, and a 
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hydrophobic lipid A moiety.6 Lipid A contains a disaccharide backbone consisting of 
glucosamines with phosphoryl residues (PO3-, H2PO3-), arabinoses (Ara4N), and acyl 
chains attached. Due to the amphiphilic nature of lipid A, separation and analytical 
characterization (e.g., desolvation and ionization) of lipid A are challenging processes.7-10 
It was proposed that B. pseudomallei may dysregulate the host immune response 
via properties inherent to the lipid A produced by this bacterium.1 Additionally, 
endotoxin activity of LPS can be modified by acylation, phosphorylation and 
glycosylation of lipid A.6 Structural determination of lipid A can help in understanding 
the effects of B. pseudomallei LPS on inflammatory activities on a molecular level.1 
While other techniques such as NMR have been attempted for the structural 
characterization of lipid A,11 mass spectrometry (MS) is a more sensitive technique, 
which is suitable for structural characterization of heterogeneous and complex lipid A 
samples. 
Early MS studies on lipid A were mostly performed using laser desorption mass 
spectrometry (LDMS).8, 11 Other techniques such as fast atom bombardment mass 
spectrometry (FAB)12, and liquid secondary ion mass spectrometry (SIMS)13, were also 
applied for analysis of lipid A. Later on, ESI-MS and MALDI-MS became efficient tools 
in determining the structures of lipid A from different strains of Gram-negative 
bacteria.10, 14-20 More recently, ultraviolet photon dissociation (UVPD) mass spectrometry 
has been used to obtain information about the fragments of lipid A, and thus made the 
structural analysis simpler.7, 21  
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A recent study examined the structures of lipid A from B. pseudomallei and B. 
thailandensis using ESI-MS.1 This study revealed the heterogeneous nature of lipid A 
and proposed a hypothetical structure of lipid A that can be used to assign lipid A ions 
found in these species. While most ions found in both species are the same, the study 
reported a doubly charged ion with an m/z of 973.59 (z=-2) to be present only in B. 
pseudomallei. These results and the potential influence of lipid A on virality of bacterial 
species indicate the need for further structural characterization of lipid A in B. 
pseudomallei and B. thailandensis.  
 
	  1.2 Mass Spectrometry 
Mass spectrometry is an analytical technique in which different molecules are 
analyzed according to their mass-to-charge (m/z) ratios. IUPAC defined mass 
spectrometry as “the study of matter through the formation of gas-phase ions that are 
characterized using mass spectrometers by their mass, charge, structure and/or physico-
chemical properties.”22 A mass spectrometer is an instrument that measures the mass of 
analyte molecules in an ionized state. J. J. Thomson, the father of mass spectrometry, was 
the first person to use a mass spectrometer and by doing so he discovered the electron and 
measured its m/z.23  
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   Figure 1-1: Schematic of a mass spectrometer 
  
A schematic of a mass spectrometer is shown in Figure 1-1. The different processes in a 
mass spectrometer are: 
1. Formation of ions and their transformation into gas phase, which happens 
in the ionization source 
2. Separation of these gas-phase ions based on their mass-to-charge (m/z) 
ratios in the mass analyzer 
3. Fragmentation of ions, and the analysis of their fragments in a second 
mass analyzer  
4. Detection of ions coming from the last analyzer and measurement of  their 
abundance with a detector that converts the ions into electrical signals 
5. Transmission of the signals from the detector to the computer 
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 The different ionization sources that are being commonly used in a mass 
spectrometer are: electron ionization (EI), chemical ionization (CI), ESI, MALDI and 
inductively coupled plasma (ICP).24 Over the years, various mass analyzers were 
developed to separate ions according to their m/z values in a mass spectrometer. Among 
the various mass analyzers, frequently used are the quadrupole, time-of-flight (TOF), ion 
trap, magnetic sector, orbitrap, or a combination of these. The detectors typically used in 
a mass spectrometer are an electron multiplier or microchannel plates.24 
 
1.2.1 Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry (MALDI-     
         MS) 
Traditional mass spectrometric instruments were used to analyze molecules with 
low molecular weights. To analyze high molecular weight compounds, it is deemed 
necessary to convert the molecules in condensed phase into ions in gas phase. It was 
difficult to perform this process, as many biopolymers are polar in nature with high 
molecular masses. Various new ionization techniques have been developed to overcome 
this problem, such as: field desorption, plasma desorption, ESI and laser desorption (LD). 
ESI and LD are the most widely used techniques for the analysis of biomolecules. 
Lasers have been used in mass spectrometry since the early 1960s, to generate 
ions for the analysis of different biomolecules in mass spectrometers.25 Transfer of energy 
to the sample when it absorbs energy at a specific wavelength of the laser is considered as 
the general principle responsible for generating ions using lasers. The main drawback of 
LD is its limitation in usage for high molecular weight molecules. Tanaka et al.26 as well 
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as Hillenkamp and Karas25 discovered the solution to the problem by using nanoparticle 
and organic molecule matrices for LDI-MS analyses involving high mass molecules.  
 This new technique was named matrix - assisted laser desorption/ionization mass 
spectrometry (MALDI-MS).25 As the name suggests, analyte is mixed with a saturated 
solution of the matrix and analyzed using MALDI-MS. MALDI-MS is a soft ionization 
technique where laser-induced desorption results in the formation of a large number of 
analyte ions that are measured with high mass accuracy and high sensitivity. Mass 
spectrometers with different combinations of lasers like ultraviolet (UV) and infrared 
(IR) are used, with UV being the most widely used laser.25 Common lasers used in 
MALDI are listed in Table 1-1.24 
Table 1-1: Different Types of Lasers Used in MALDI-MS and Their Wavelengths 
LASER WAVELENGTH 
Nitrogen 337 nm 
Nd:YAG 266 nm or 355 nm 
Er:YAG 2.94 µm 
Carbon dioxide 10.6 µm 
 
 The general principle of MALDI-MS is shown in Figure 1-2. Sample preparation 
involves co-crystallization of the sample with a matrix. The matrix along with the analyte 
is then subjected to laser irradiation. The photons from the laser cause desorption and 
ionization of both the matrix and the sample in the gas phase. These ions are then 
accelerated through a drift tube where they are separated according to their speed. 
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Figure 1-2: Principle of MALDI-TOF MS.27 Reprinted with permission from   
                    reference 27. 
 The speed with which the ions move in the drift tube depends on its m/z. Ions with 
a high mass-to-charge ratio move slowly in the drift tube and ions with a low mass-to-
charge ratio move with a higher speed. Hence, smaller ions reach the detector first and 
larger ions reach the detector more slowly. This is given by the equation 1-1:28 
m/z = 2eU (t*L-1)2  (eq. 1-1) 
 In the above equation, m stands for mass, z for charge state, e for elementary 
charge, U for potential difference, t for time-of-flight to the detector, and L for the length 
of the drift tube. 
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Figure 1-3: Schematic of MALDI-MS.29 Reprinted with permission from reference 29. 
 
The mass analyzer used in MALDI is known as time-of-flight (TOF) as the mass 
is determined by the time the ion is in the drift tube. A schematic of MALDI-MS with the 
TOF mass analyzer is shown in Figure 1-3. The MALDI-MS instrument used in this 
study has two mass analyzers, a linear TOF and a reflectron TOF. A reflectron typically 
increases the time-of-flight of an ion in the drift tube. Use of reflectron TOF results in an 
increase in the mass resolution as the ion spends more time in the drift tube.28 
 Selection of a suitable matrix is of primary importance as it enhances ion 
formation by photoexcitation or photoionization of the matrix molecules.28 The analyte is 
co-crystallized with saturated matrix solution and, upon laser irradiation, the matrix is 
vaporized along with the analyte.  
The matrix can act as both proton donor and proton acceptor,30 and hence can 
help ionization of the analyte molecules both in positive ion mode and negative ion 
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mode, respectively. Different matrices are used for analyzing different classes of 
molecules. The most commonly used matrices are provided in Table 1-2.24, 28 
 
  Table 1-2. Type of Matrices Used for Different Types of Biomolecules in MALDI-  
         MS 
ANALYTE MATRIX 
Peptides/Proteins α-Cyano-4-hydroxycinnamic acid (CHCA), 2,5-
Dihydroxybenzoic acid (DHB), Sinapic acid (SA) 
Oligonucleotides Trihydroxyacetophenone (THAP), 3-Hydroxypicolinic 
acid (HPA) 
Carbohydrates α-Cyano-4-hydroxycinnamic acid (CHCA), 2,5-
Dihydroxybenzoic acid (DHB), 
Trihydroxyacetophenone (THAP) 
Lipids Dithranol (DIT), 2,5-Dihydroxybenzoic acid (DHB) 
  
1.2.2 Electrospray Ionization Mass Spectrometry (ESI-MS) 
In 1989, John Fenn, introduced a new method of ionization known as ESI, which 
is a soft ionization technique and ionizes proteins by multiple charging.31 Development of 
ESI and MALDI solved the problem of structural destruction of analyte molecules by 
different ionization methods. The major advantage of ESI is that it forms ions with 
multiple charges. Multiple charging lowers the m/z of the ions formed, allowing them to 
fall in a mass range suitable for all common mass analyzers. ESI has become a powerful 
	   	  
10	  
tool for the analyses of large biomolecules like proteins and nucleic acids. Applications 
of ESI are not limited to biological molecules and proteomics, but are spread out to a 
range of analytes like polar organic molecules32, inorganic molecules33 and metal-organic 
complexes.34 
 
Figure 1-4: Principle of ESI-MS.35 Reprinted with permission from reference 35. 
The principle of ESI-MS is shown in Figure 1-4. ESI-MS is composed of an ion 
source, mass analyzer and detector. The ions are formed at atmospheric pressure in the 
ionization chamber, and are then transferred to the mass analyzer via ion optics-like 
skimmer, focusing lens, multipole, etc., which help maintain a stable trajectory of the 
ions. The role of the mass analyzer is to separate the ions based on their m/z values before 
the ions are further passed to the detector. All of these processes are conducted under a  
high vacuum, typically 10-3 torr to 10-6 torr, as the gas-phase ions are short-lived and 
highly reactive.36 
 A very low concentration of the analyte solution is injected into the mass 
spectrometer by a syringe pump through a stainless steel capillary. The flow rate is 
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typically between 1-10 µL/min. A voltage of 2-6 kV is applied to the tip of the capillary 
that results in the formation of an electric field. The electric field will be the highest at the 
tip of the capillary. The effect of the electric field increases as the voltage is increased.36 
At low voltages, the droplets formed at the tip of the capillary are spherical. As the 
charges accumulate at the tip, the droplets elongate and when the surface tension is 
broken, the shape of the droplets changes to a cone. This cone is known as a Taylor 
cone.37 An aerosol of electrospray droplets of the sample solution is formed due to the 
high electric filed. The flow of N2 gas around the capillary improves nebulization and 
also helps in directing the spray of ions towards the mass spectrometer. Solvent 
evaporation causes the charged droplets to decrease in size, which is supported by the 
flow of nitrogen (drying gas). 
 Different types of mass analyzers are used in ESI-MS such as magnetic (B)/ 
electric (E) sector, linear quadrupole ion trap (LIT), three-dimensional quadrupole ion 
trap (QIT), orbitrap, TOF, and ion cyclotron resonance (ICR).24, 38-39 
The most commonly used detector in ESI-MS is the electron multiplier. In this 
type of detector, the ions strike a metal or a semiconductor plate called a dynode, which 
emits secondary electrons.24 The secondary electrons are accelerated towards the second 
and subsequent dynodes. The electrons emitted are increased at each dynode. There are 
several types of electron multipliers such as channel electron multipliers (CEMs) or 
microchannel plates (MCPs).38 
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1.2.2.1 Mechanisms of ion formation in ESI:  
Two mechanisms have been proposed to explain the process of gas-phase ion 
formation in ESI: charge residue model (CRM) and ion evaporation model (IEM).36 
 
Charge Residue Model: Dole proposed this model in 1968.40, 41 This mechanism is called 
the charge residue model because the analyte retains a charge in the gas phase during the 
ES process. The mechanism proceeds as follows: 
 An extremely small charged droplet is formed due to solvent evaporation and 
coulombic explosion, which contains only one analyte molecule. Desolvation of this 
droplet causes the charge to retain on the analyte. The repulsion of charges tends to 
increase until the droplet reaches the Rayleigh stability limit. 
Rayleigh stability limit is given by the following equation 1-2: 
 q = 8π (εγR3)1/2  (eq. 1-2) 
 In the above equation, q is the charge, ε is the electrical permittivity of the 
surrounding medium, γ is the surface tension of the solvent, and R is the radius of the 
droplet. 
 
Ion Evaporation Model: Iribarne and Thomson proposed this mechanism.37, 42 Due to 
repeated solvent evaporation and coulombic explosion, the radii of the charged droplets 
decrease to a given size. When the radii of the droplets reach the size R ≤ 10 nm, direct 
emission of the solvated ions is possible.  
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Major advantages of ESI-MS are: 
a. Ability to form and detect multiply charged ions of the analyte 
b. High sensitivity 
c. Ability to measure high molecular weight analytes 
1.3 Lipopolysaccharide (LPS) 
Various amphiphilic macromolecules are found to be present on the outer 
membrane of a Gram-negative bacterium. LPSs are considered to be one of these 
macromolecules with exceptional significance that are seen on the outer membrane of 
bacteria.13 LPSs are amphiphilic molecules7, which are bound to the Gram-negative 
bacterium by a hydrophobic anchor known as lipid A.11 LPSs are involved in regular 
membrane functions, but also have a unique job related to immune response. By 
stimulating the formation of antibodies, LPSs are involved in the recognition of host’s 
defense system during infection.43 
General structure of a LPS is shown in Figure 1-5. LPSs contain three structural 
components, which are covalently bound to each other: (i) a long “O-specific 
polysaccharide” (OPS) consisting of repeating units of monosaccharide′s (typically from 
one to seven) that are responsible for O-antigenic specificity, (ii) a core oligosaccharide 
region (core OS), which is subdivided into an inner core and outer core, and (iii) a 
hydrophobic region termed as “lipid A” that anchors the LPS to the outer membrane of 
Gram-negative bacteria by hydrophobic interactions.13  
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These LPSs are further divided into three types based on their structural 
components.13 A smooth (S-type) LPS consists of all three domains, which are common 
in wild-type strains of bacteria. These are also known as long chain LPSs.  A semi-rough 
(SR-type) LPS (also called a short chain LPS) has only one O-chain repeating unit 
attached to the core oligosaccharide. Rough (R-type) LPSs are completely devoid of the 
O-specific polysaccharide chain due to genetic defects.44 The endotoxic activity of S-type 
LPS and R-type LPS were compared and it is indicated that the endotoxic activity is due 
to the lipid A moiety.13  
  
Figure 1-5: General structure of a LPS.6 Reprinted with permission from reference 6. 
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The three major components of a LPS are O-antigenic region, core region, and 
lipid A portion. The O-specific antigen has high structural variability45 consisting of 
repeating oligosaccharide units. Depending upon the nature, sequence, substitution, and 
type of linkage, the structure of these repeating units differ from strain to strain.46 
 The core oligosaccharides are structurally identical47 and hence, show less 
variability. The core consists of two regions: an inner core and an outer core. The outer 
core is comprised of hexoses, while the inner core contains heptapyranoses and 3-deoxy-
2-manno-2-octulosonic acid (Kdo). H3PO4 substitutes heptapyranose and Kdo. The high 
density of negatively charged residues has a physiological significance of concentrating 
the bivalent cations (Ca2+ and Mg2+) within the cell that are required for structural and 
functional integrity of the outer membrane.9, 13 
 Lipid A constitutes the toxic and immunomodulating component of LPS.48 Lipid 
A, a phosphoglycolipid that acts as an anchor in binding the LPS to the outer membrane 
has pathophysiological importance as it has intense effects when injected into a mammal. 
These effects include induction of endotoxin shock,49 pyrogenecity,50 macrophage 
activation,51 interferon production,52 and tumor regression.53  
 General structure of lipid A is shown in Figure 1-6. Lipid A is primarily 
composed of β-D-GlcpN-(1à6)-α-D-GlcpN disaccharide backbone, but 2,3-diamino-
2,3-deoxy-glycopyranose residues are also seen in the disaccharide backbone in some 
bacteria.54-55 
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The disaccharide backbone is substituted with phosphoryl residues, ethanolamine 
phosphate, 4-amino-4-deoxy-arabinose-1-phosphate as well as with a variety of acyl 
chains (chain lengths are typically between 10 and 30 carbon atoms). 
 
Figure 1-6: General structure of lipid A 
 Lipid A often contains two partially substituted phosphoryl residues.8 One of 
these residues is linked to the hydroxyl group of the reducing glucosaminyl residue 
(GlcN I) and the other one is attached in position 4′ of the non-reducing glucosamine 
group (GlcN II). The carbohydrate backbone is acylated at positions 2, 3, 2′, and 3′ by 
four acyl chains. The acyl chains at positions 2′ and 3′ are further acylated depending on 
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the bacterial strain at their 3-hydroxyl group by dodecanoic acid (C12:0), tetradecanoic 
acid (C14:0) or hexadecanoic acid (C16:0).56-57 
 Changes in acylation, phosphorylation, or glycosylation alter the endotoxic 
activity of the LPS in the Gram-negative bacteria.58 Any deviation from the standard 
biphosphorylated hexa-acyl lipid A might lead to reduced toxicity9 or even anti-tumor 
activity.59 Phosphorylation of lipid A plays an important role in endotoxicity. The 
endotoxicity is reduced when a phosphate group is removed.9, 60 Any substitutions on the 
phosphate group might also alter the endotoxic activity. When an arabinose sugar 
(Ara4N) is attached to the phosphate group, it increases the bacterial resistance to the 
host’s cationic antimicrobial peptides.58, 61 
 
1.4 MALDI-MS Analysis of Lipid A 
MALDI-MS has been widely used for structural characterization of LPSs.6, 62 One 
major advantage with MALDI-MS is formation of singly charged ions, which makes it 
easier to interpret the spectra. Due to the amphipathic nature of LPS molecules, sample 
preparation plays a very important role. Use of different matrices enhances the signal-to-
noise ratio in the mass spectra.63  
Schiller, et al. used MALDI-MS to study different classes of lipids including 
phospholipids. In this study, they tested different matrices like DHB, SA, and CHCA. Of 
the three matrices used, DHB gave the best results because it was shown to have better 
crystallization properties. 64 ATT was used as the MALDI matrix for the analysis of 
oligosaccharides for a long time.65 DHB was used as a matrix for analysis of lipids and 
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phospholipids66, and it is one of the mostly used matrices for the MALDI-MS analyses of 
lipids (Table 1.2). 
Four different matrices such as ATT, DHB, THAP, and CMBT (5-chloro-2-
mercaptobenzothiazole) were used by Li et al. for the analysis of lipid A from E. coli 
O116 and some other Gram-negative bacteria.63 EDTA has also been used as a matrix 
additive in this study.  While most ions were the same, some lipid A ions were different 
for each matrix. CMBT with EDTA was considered to yield the best results for studying 
the structures of lipid A molecules.63 
Stübiger, et al. used ATT as a matrix for MALDI-MS analysis of oxidized 
phospholipids. This work confirmed that use of ATT as a matrix reduces fragmentation 
of intact molecules and enhances sensitivity.67 
 
1.5 ESI-MS Analysis of Lipid A 
 ESI-MS has been in use for the analysis of lipid A for a long time.14-15, 17, 61	  Chan, 
et al. used ESI-MS and ESI-MS/MS for studying the structures of lipid A molecules from 
different strains of bacteria. A triple quadrupole instrument was used in this study. CID 
was performed on the lipid A samples to obtain structural information of these lipid A 
molecules. With CID, different groups of fragment ions were obtained, which helped in 
structural identification of lipid A.18 
 Kussak, et al. employed QIT-MS to identify the position of fatty acids on lipid A 
molecules from Gram-negative bacteria. The major advantage of an IT instrument is its 
ability to perform different levels of fragmentation (MSn). Tandem mass spectrometry 
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experiments help in determining the degree of acylation and positions of different acyl 
chains. In this study, lipid A was dissolved using 1:1 chloroform/methanol and analyzed 
by IT-MS.14 
 Jones, et al. characterized the structure of lipid A from Yersinia pestis and also 
identified its phosphorylation patterns. An ion trap Fourier transform ion cyclotron 
resonance (FT-ICR) mass spectrometer was used in this study. The position of Ara4N on 
lipid A molecules was also identified in this study along with the position of phosphoryl 
groups.68  
 Novem et al. studied the lipopolysaccharides of B. pseudomallei KHW and B. 
thailandensis ATCC 700388 strains.1 In this study, lipid A profiles of both bacteria were 
studied by using ESI-MS. A hypothetical structure (shown in Figure 1-7) was proposed 
based on MS and MS/MS data. In the Figure 1-7: A, B, and C depict the losses of 
phosphorylated arabinose, Ara4N, and HPO3, respectively. 
 
Figure 1-7: Hypothetical structure proposed by Novem et al.1 of the major lipid A    
         species in B. pseudomallei. Reprinted with permission from reference 1. 
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 This structure explained the structures of most lipid A ions observed in ESI-MS 
spectra. This study hypothesized that a difference of 2-OH (shown with an arrow in 
Figure 1-7) on C14:0 acyl chain at position 3 was observed between the lipid A structures 
of B. pseudomallei and B. thailandensis.1 Detection of this modification is believed to 
lead to a doubly charged ion with an m/z value of 973.59 found only in B. pseudomallei 
lipid A. Considering that this structure is hypothetical, further studies of Burkholderia 
lipid A are needed. 
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Chapter 2 
  
Materials and Methods 
 
2.1 Isolation of Lipid A 
2.1.1 Materials for Lipid A Isolation 
 B. pseudomallei (strain 1026b), B. thailandensis (strain E264), flasks, Luria Broth 
(LB) media, proteinase K, RNase, DNase, phenol, milli-Q-DI H2O, 70 mL UC 
polybottles, 12 mL-capacity slide-A-lyzer dialysis cassettes with 7 kDa molecular weight 
cutoff were provided in the laboratory of Dr. R. Mark Wooten at the University of Toledo 
College of Medicine and Life Sciences. 
 
2.1.2 Lipopolysaccharide and Lipid A Isolation Protocol 
 Bacterial strains were grown in a biosafety level 3 facility at the University of 
Toledo College of Medicine and Life Sciences by trained personnel (Dr. Michael Bechill) 
following the safety guidelines and previously published protocols for lipid A isolation.69-
73 The bacteria were cultured on a low salt LB (Luria Broth) agar plate which was 
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maintained at 37 °C overnight. 500 mL of LB media was inoculated with 1x106 bacteria 
per milliliter in a 1 L beveled flask and incubated at 37 °C at 200 rpm until the bacteria 
were at mid-log phase. This took approximately 10 h. 40 mL aliquots of the bacteria were 
then aliquoted into 50 mL tubes and centrifuged. The supernatant was discarded. The 
above steps were repeated until all 500 mL of LB media was pelleted. The pellets were 
washed twice with phosphate buffered saline (PBS) and centrifuged at 14,000 x g for 5 
min. The bacteria were suspended in 25 mL of 90% phenol at 68 °C.   
 Hot phenol-water extraction was performed. The lysate obtained in the previous 
step was placed in a heat block at 68 °C. 25 mL of Milli-Q-DI H2O was added to the 
lysate and transferred to a 50 mL BD Falcone tube. The tube was placed in the 68 °C heat 
block and vortexed for 20 min intermittently. The aqueous phase was collected once the 
lysate was cooled to room temperature. 12 mL of the aqueous phase was injected into two 
7 kDa MW Slide-A-Lyzer dialysis cassettes. The aqueous phase was dialyzed against 
Milli-Q-DI H2O (~1800 mL per change for 5 changes in a 2 L beaker) to remove residual 
phenol. The initial wash was disposed of as hazardous waste and remainder of the washes 
were disposed of in the municipal waste stream. Insoluble cell debris was pelleted at 
14,000 x g for 5 min. The supernatant was lyophilized to be concentrated. The lyophilizer 
collection chamber was cleaned with 70% ethanol (EtOH) and rinsed with Milli-Q-DI 
H2O. The lyophilizer was turned on and set to cool to a temperature of -50 °C. Once 
cooled, the pump was turned on and the lyophilizer was allowed to reach vacuum and 
was equilibrated for 30-60 min.  
 All of the aqueous phase from previous step was added to a wide mouth freeze 
dry flask and covered with plastic wrap. The sample was placed in a -50 °C freezer at a 
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45° angle until completely frozen. The sample was then placed in dry ice once it was 
completely frozen and it was lyophilized. The lyophilized sample was transferred to a 50 
mL BD Falcone tube. The crude carbohydrate portion preparation was solubilized at a 
concentration of ~30 mg/mL in 100 mM Tris-HCl. To the above portion, RNase (50 
µg/mL) and DNase (50 µg/mL) were added and the sample was left at 37 °C overnight. 
Then proteinase L (100 µg/mL) was added to the sample and the sample was incubated at 
65 °C for 1 h. The lysate was ultra-centrifuged to obtain a gel-like pellet of LPS. The 
pellet of LPS was then resuspended in 40 mL of limulus amebocyte lysate (LAL) reagent 
water and transferred to a 15 mL conical tube to lyophilize and concentrate the purified 
LPS.  
 Lipid A was separated from LPS by suspending 0.5 mg of lyophilized LPS in 100 
µL of 0.01M TEA citrate and vortexing vigorously. The suspension was sonicated 4 
times for 30 s each. The sample was incubated at 100 °C for 2 h vortexing every 15 
minutes for 30 s. The final lipid A samples were stored at 4 °C in a refrigerator until 
needed. 
 
2.2. O-deacylation of Lipid A (Partial and Complete O-deacylation) 
 The lipid A samples were subjected to deacylation protocol using ammonium 
hydroxide and methylamine (Sigma). For partial O-deacylation, the lipid A sample was 
dissolved in 28% of ammonium hydroxide (NH4OH) solution74 to a concentration of 1 
mg/mL and then stirred for 5 h at 55 oC. Complete O-deacylation of the lipid A sample 
was achieved by using a 41% methylamine (CH3NH2) solution.75 The sample was 
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dissolved in the methylamine solution and stirred for 5 h at 37 oC. Both sample solutions 
were then evaporated using a vacuum concentrator and resuspended in 2:3:2 chloroform: 
methanol: water (v/v/v). 
 
2.3 Mass Spectrometry of Lipid A 
2.3.1 Materials  
HPLC-grade methanol and water, and ACS-grade chloroform were purchased from 
Fisher Scientific. Matrices ATT, DHB, and THAP were purchased from Sigma. 
  
2.3.2 MS Experiments  
 Purified lipid A samples were further extracted using a mixture of chloroform, 
methanol, and water (2:3:2; v: v: v). ~ 0.5 mg of lyophilized lipid A sample was 
dissolved in 0.5 mL of chloroform, methanol, and water (2:3:2; v: v: v) mixture. Samples 
were then vortexed and allowed to sit until there was a clear separation into two 
immiscible layers. Lipid A for MS analyses was taken from chloroform/methanol 
(bottom) layer. MALDI-MS instrument UltrafleXtreme (Bruker) and ATT matrix were 
used for MALDI-MS analyses. 1 µL of the sample solution was mixed with 1 µL of 
matrix solution and deposited onto a MALDI plate. 
 For ESI-MS, lipid A was extracted using the solvents mentioned above. 
Chloroform/methanol layer (bottom layer) was injected into the ESI source of the mass 
spectrometer at the flow rate of 1.5 µL/min using a syringe pump. MS, MS/MS, and 
MS/MS/MS spectra were obtained in mass spectrometry facility at Fred Hutchison 
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Cancer Research Center (FHCRC, Seattle, WA) using an Orbitrap Elite (Thermo) mass 
spectrometer. Also, Waters Q-TOF-ESI-MS was used to obtain both MS and MS/MS 
data. The source temperature was 80 °C, desolvation temperature was 120 °C, capillary 
was maintained at a voltage of 2.4 kV, and the sample cone was 30 V.  Additionally, MS 
and MS/MS experiments were also performed on Orbitrap Fusion (Thermo). A spray 
voltage of 2.2 kV was used. For MS/MS collision energy of 35 V was used. 
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Chapter 3 
 
Results 
 
3.1. MALDI-MS and MALDI-MS/MS Analyses of Lipid A from B. pseudomallei     
       Strain 1026b and B. thailandensis Strain E264 
Lipid A was successfully isolated from B. pseudomallei strain 1026b and B. 
thailandensis strain E264 using the hot phenol-water extraction method. Liquid-liquid 
extraction of lipid A in chloroform, water and methanol was performed immediately 
before MS analyses of lipid A. Matrices like ATT, DHB, and THAP were tested for 
MALDI-MS analyses of lipid A, but ATT was chosen as the matrix for further MALDI-
MS analyses as it gave better spectra with higher intensities of the ions than DHB and 
THAP. MALDI-MS spectrum of B. pseudomallei 1026b lipid A in negative ion mode 
(Figure 3-1) using ATT as matrix shows intense peaks at m/z values of 1363.988, 
1443.968, 1495.023, 1580.040, 1670.135, 1722.138, and 1801.231 that correspond to 
deprotonated lipid A molecules. The lipid A ions were assigned using a hypothetical
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structure (M=2113.383) shown in the inset of Figure 3-1, which was derived by addition 
of a C12:1 (M=182.159) acyl chain to a hypothetical structure (M=1933.231) proposed by 
Novem et al.1 Since an ion with an m/z value of 1580.040 was observed, but could not be 
explained by the proposed structure by Novem et al. (Figure 1-7), a new hypothetical 
structure was proposed.1 When compared with the hypothetical structure proposed by 
Novem et al.1 (Figure 1-7) the main difference is a C12:1 acyl chain attached to the 3-
hydroxyl group on the ester linked acyl chain (C14:0) and a 2-hydroxy tetradecanoic acid 
C14:0(2-OH) acyl chain located at position 3 on the disaccharide backbone. This ester 
linked acyl chain is located at position 3´ on the sugar backbone. The primary reason for 
proposing a new hypothetical structure was to structurally characterize the lipid A species 
with an m/z value of 1580.040 as this lipid A species was believed to be the main 
difference between lipid A species from B. pseudomallei 1026b and B. thailandensis 
E264. 
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 Figure 3-1: A MALDI-MS spectrum of lipid A from B. pseudomallei 1026b  
          acquired in negative ion mode using ATT as the matrix. Inset:     
                               hypothetical structure of the parent lipid A molecule. 
In the MALDI-MS spectrum of lipid A from B. pseudomallei 1026b shown in 
Figure 3-1, the ion with an m/z of 1801.231 can be formed by the loss of a secondary 
C12:1 acyl chain located on the C14:0 acyl chain at position 3′	  and an Ara4N attached to the 
phosphate at position 1 on the sugar backbone of the parent structure. Loss of another 
Ara4N attached to the H3PO4 at position 4 results in an ion with an m/z of 1670.135. Loss 
of PO3-, from the ion with an m/z of 1801.231, gives the ion with an m/z value of 
1722.138. Further loss of a primary C14:0 acyl chain at position 3´, results in formation of 
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an ion with an m/z value of 1495.023. Similarly, the ion with an m/z of 1443.968 is due to 
loss of the primary ester linked C14:0 acyl chain, at position 3, from the ion with an m/z 
value of 1670.135. Additional loss of HPO3 at position 4 on the disaccharide backbone 
results in formation of an ion with an m/z value of 1363.988. 
The MALDI-MS spectrum of the lipid A species from B. thailandensis E264 
obtained in negative ion mode (Figure 3-2) contains many of the same deprotonated lipid 
A species (e.g., m/z values of 1364.862, 1443.824, 1494.908, 1670.027, 1722.102, and 
1801.076) as the MALDI-MS spectrum of B. pseudomallei 1026b, but the ion with an 
m/z of 1580.040 is unique for lipid A originating from B. pseudomallei 1026b (Table 3-
1). Ions with m/z values of 1402.627, 1896.161, 1967.289, and 2039.259 (Table 3-1) 
were also unique for lipid A from B. pseudomallei 1026b, but their intensities were 
inconsistent and relatively low.    
In the MALDI-MS spectrum of B. thailandensis E264 lipid A, the ion with an m/z 
of 1801.076 is due to loss of an Ara4N attached to the phosphate group at position 1 of 
the disaccharide backbone from the parent lipid A molecule (shown in the inset of figure 
3-2).1 Loss of PO3- located at position 1 from this lipid A ion with an m/z of 1801.076, 
results in formation of an ion with an m/z of 1722.102. Loss of Ara4N attached to the 
phosphate located at position 4´ from lipid A ion with an m/z of 1722.102 forms an ion 
with an m/z value of 1590.048. The ion with an m/z value of 1443.824 is due to loss of 
two Ara4N moieties and a C14:0 acyl chain from the parent molecule. Loss of another 
HPO3 results in the formation of an ion with an m/z of 1364.862. All intense ions 
mentioned above, except the ion with an m/z of 1580.040, can be deduced from the 
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hypothetical structure of B. pseudomallei  lipid A (m/z of deprotonated molecule ~ 
1932.20) proposed by Novem et al.1 (Inset of Figure 3-2). 
 
 
 Figure 3-2: A MALDI-MS spectrum of lipid A species from B. thailandensis  
          E264 in negative ion mode using ATT as the matrix. Inset:   
                     hypothetical structure of the parent lipid A molecule proposed by  
          Novem et al.1  
 The acyl chain that is present at position 3 on the disaccharide backbone is a 
(C14:0), which in the case of our proposed lipid A structure from B. pseudomallei 1026b is 
a C14:0(2-OH).1, 4
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 While the lipid A ion with an m/z of ~1932 was not observed in our mass spectra,1 
the ions detected were derived from the structure proposed by Novem et al.1 if one 
considers the neutral losses of Ara4N residues, phosphoric acid and acyl chains, as well 
as, their losses upon fragmentation from the lipid A structures. For example, the ion with 
an m/z of 1801.231 is due to neutral loss of an Ara4N (M=~131) from the lipid A 
structure with an m/z of ~1932. An additional loss of PO3- will yield the ion with an m/z 
of 1722.138. The ion with an m/z of 1670.135 is due to loss of an Ara4N from the ion 
with an m/z of 1801.231. Loss of phosphorylated Ara4N along with a C14:0 acyl chain 
from the parent lipid A molecule gives rise to an ion with an m/z of 1495.023. Additional 
loss of another Ara4N from this ion results in an ion with an m/z of 1363.988. The lipid A 
ion with an m/z value of 1443.968 is due to loss of two Ara4N molecules, C12:0, and C14:0 
from the parent lipid A ion. Loss of HPO3 from the lipid A ion with an m/z of 1443.968 
results in the formation of lipid A ion with an m/z value of 1363.988. However, as 
mentioned above, an intense ion with an m/z of 1580.040 could not be assigned using the 
structure described by Novem et al.1  
However, all ions can be described by using a hypothetical lipid A structure with 
(M= ~2113), which is shown in the inset of Figure 3-1. If this structure is considered, the 
ion with an m/z of 1580.040 would be a pentaacylated structure including two phosphoryl 
residues (Figure 3-7, inset). MALDI-MS/MS data yielded additional information about 
structures of lipid A ions confirming the assignments mentioned above. 
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Table 3.1: Experimental and Theoretical Masses of Each Lipid A Ion from     
      B. thailandensis and B. pseudomallei Along with Their Composition 
Exp mass 
(BTLA) 
Exp mass 
(BPLA) 
Ion (m/z) from 
ChemBioDraw 
Acyl chains, phosphates and arabinoses 
1363.882*X 1363.998*X 1363.955 
Two C16:0(3-OH), C14:0(3-OH), C14:0, one 
phosphate 
1443.824*X 1443.968*X 1443.922 
Two C16:0(3-OH), C14:0(3-OH), C14:0, two 
phosphates 
1494.908* 1495.023* 1495.014 
Two C16:0(3-OH), one C14:0(3-OH), C14:0, 
one phosphate, one Ara4N 
- 1580.040 1580.047 
Two C14:0, one C14:0(3-OH) with secondary 
C12:1, one C16:0(3-OH), two phosphates 
1590.048* 1590.212* 1590.149 
Two C16:0(3-OH), two C14:0(3-OH), C14:0, 
one phosphate 
1670.027*X 1670.135*X 1670.115 
Two C16:0(3-OH), two C14:0(3-OH), C14:0, 
two phosphates 
1722.102* 1722.138* 1722.207 
Two C16:0(3-OH), two C14:0(3-OH), C14:0, 
one phosphates, one Ara4N 
1801.076*X 1801.231*X 1801.173 
Two C16:0(3-OH), two C14:0(3-OH), C14:0, 
two phosphates, one Ara4N 
* - based on Novem′s structures. X – based on deacylation studies and MS/MS. Ions 
with an m/z of 1402.627, 1896.161, 1967.289, and 2039.259 were seen only in lipid A 
from B. pseudomallei. 
 
. 
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For example, MS/MS of the parent ion with an m/z of 1801.231 (Figure 3-3) 
reveals the presence of two ions with an m/z of 1670.614 and 1495.670, which were also 
observed in the MS spectrum of B. pseudomallei lipid A (Figure 3-1). The ion with an 
m/z of 1670.614 is due to loss of an Ara4N group and the ion with an m/z of 1495.670 is 
due to loss of HPO3 and a C14:0 acyl chain. The ion with an m/z of 1102.928 arises due to 
loss of a phosphorylated Ara4N and two C14:0 acyl chains. Two cross-ring fragments 
were also observed in the spectrum: ions with m/z values of 393.295 (2,4A2) and 284.138 
Figure 3-3: A MALDI-MS/MS spectrum of the ion with an m/z of 1801.231 
        of lipid A from B. pseudomallei 1026b in negative ion mode     
        using ATT as the matrix. Inset: hypothetical structure of the   
        parent lipid A molecule 
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(0,2X2). The cross-ring fragments were assigned according to Domon and Costello’s 
nomenclature of carbohydrate fragmentation.76 The peak at an m/z value of 244.240 
confirms the presence of C14:0(3-OH). The presence of phosphoryl residues was 
confirmed by the presence of ions with m/z values of 79.583 (PO3-), 97.676 (H2PO4-), 
159.843 (HP2O6-), and 177.830 (H3P2O7-). 
 From the MS/MS data of the ion with an m/z of 1670.135, fragments are assigned 
as shown in Figure 3-4.  
   
  
 
 
Figure 3-4: A MALDI-MS/MS spectrum of ion with an m/z of 1670.135 of 
         lipid A from B. pseudomallei 1026b in negative ion mode using 
         ATT as the matrix. Inset: hypothetical structure of the parent   
         lipid A molecule 
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 Loss of H3PO4 yields the ion with an m/z of 1572.508 and loss of C14:0(3-OH) 
acyl chain results in formation of the ion with an m/z of 1426.551. Additional loss of 
another H3PO4 results in an ion with an m/z of 1328.695, confirming the presence of two 
phosphate groups. The ion with an m/z value of 1102.759 is due to the loss of one C14:0(3-
OH), one C14:0, and H3PO4 from the parent molecule. A cross-ring fragment with an m/z 
value of 284.005 is identified. Presence of two phosphate groups is confirmed by the ions 
with m/z values of 97.645 (H2PO4-), and 159.785 (HP2O6-). 
There are two mechanisms involved in the removal of acyl chains from lipid A: 
charge-driven process and charge-remote process.14 Figure 3-5 explains the mechanisms. 
In charge-driven process, neutral loss of an acyl chain as a ketene derivative is observed, 
and in the charge-remote process the acyl chain is lost as free fatty acid.14 For charge-
driven process, the presence of phosphate anion at position 4´ was considered very 
important.14 The negative charge on the phosphate anion attracts the α-hydrogen of the 
acyl chain at position 3´. This results in the elimination of acyl chain as a neutral ketene 
derivative. In charge-remote fragmentation, the negative charge will remain on the 
phosphate group and it is not involved in the fragmentation.14 The acyl chains are 
eliminated as neutral fatty acids. 
	   	  
36 
	  
	  
 Figure 3-5: Fragmentation mechanisms: (A) Charge-driven fragmentation      
            (B) Charge-remote fragmentation	  
Loss of an ester moiety as a free fatty acid and neutral ketene derivative results in 
formation of two different ions which differ by 18 units. This helps in identifying the acyl 
chains at position 3´. For example, in the MALDI-MS/MS spectrum of lipid A ion with 
an m/z value of 1670.135 (Figure 3-4), two peaks with a mass difference of 18 are 
observed at m/z values of 1328.695 and 1346.714, indicating that a C14:0(3-OH) is lost as 
free fatty acid and also as a ketene derivative. 
 The following peaks were assigned in MS/MS data obtained for the parent ion 
with an m/z of 1363.993 (Figure 3-6). The ion with an m/z of 1120.433 was due to the 
loss of the C14:0(3-OH) acyl chain. Two cross-ring fragments were also observed with m/z 
values of 747.488 and 807.487, which were assigned as 0,2A2 with loss of water and 0,4A2 
with loss of C14:0(3-OH) respectively, using the nomenclature of Domon and Costello.76 
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The presence of the C14:0(3-OH) group is confirmed by the presence of the ion with an 
m/z of 244.240. Also, two ions with m/z values of 79.610 and 97.630 confirm the 
presence of phosphate groups (PO3- and H2PO4-, respectively). 
 
  
 
 
 
 MALDI MS/MS spectrum of the ion with an m/z of 1580.040 is shown in Figure 
3-7. The ions at m/z of ~79 (PO3-) and 97 (H2PO4-) indicate that this lipid A species is 
phosphorylated. Additionally, the pyrophosphate ion at m/z of ~ 159 (HP2O6-) indicates 
that this lipid A species is biphosphorylated.16  
Figure 3-6: A MALDI-MS/MS spectrum of ion with an m/z of 1363.993 of 
         lipid A from B. pseudomallei 1026b in negative ion mode using 
         ATT as the matrix. Inset: hypothetical structure of the parent    
         lipid A molecule. 
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The most intense fragment ion in the MALDI-MS/MS spectrum of lipid A ion 
with an m/z of 1580 has an m/z of ~1444. Since the ion with this m/z was detected in B. 
pseudomallei 1026b lipid A spectrum (Figure 3-1), it is interesting to compare MS/MS 
spectra of ions with m/z of 1580 and 1444 (Figures 3-7 and 3-8, respectively). Ions with 
m/z of ~79 (PO3-), 97 (H2PO4-), and 159 (HP2O6-) are very intense in the MS/MS 
spectrum of 1444, indicating that this ion is also biphosphorylated.  Additionally, the 
Figure 3-7: A MALDI-MS/MS spectrum of ion with an m/z of 1580.040 of 
         lipid A from B. pseudomallei 1026b in negative ion mode using 
         ATT as the matrix. Inset: hypothetical structure of the parent   
         lipid A molecule 
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intense fragment ions found in both MS/MS spectra show the same m/z values, and can 
be related to both structures with m/z of ~1444 and ~1580. 
  
 
  
 
 
 
For example, an ion with an m/z of ~1346 is likely formed by the neutral loss of 
phosphoric acid from an ion with an m/z of 1444. The ion with an m/z of ~1102 is 
obtained by additional loss of a C14:0(3-OH) acyl chain from an ion with an m/z of 1346. 
The ion with an m/z of ~1217 is due to the loss of all primary and secondary ester linked 
acyl chains, which is further confirmed by deacylation studies (described later). In the 
Figure 3-8: A MALDI-MS/MS spectrum of ion with an m/z 1443.968 of     
                 lipid A from B. pseudomallei 1026b in negative ion mode using 
        ATT as the matrix. Inset: hypothetical structure of the parent    
        lipid A molecule 
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MALDI-MS/MS spectrum of the lipid A ion with an m/z value of 1580.040, an ion due to 
glycosidic cleavage along with loss of phosphoric acid and water molecule is observed 
with an m/z value of 998.513. This ion with an m/z value of 998.513 is not seen in the 
MALDI-MS/MS spectrum of the lipid A ion with an m/z value of 1443.968.  
A cross-ring fragment with an m/z of ~747 is also seen in MS/MS spectra of both 
ions with an m/z of 1444 and 1580 but it was low in intensity in the latter spectrum. 
Based on this data, it can be proposed that the lipid A ion with the m/z of ~1580 likely 
involves a structural motif that has the mass of ~136 Da added to the lipid A structure 
with an m/z of 1444. There are also some fragment ions that are different. There is an ion 
with an m/z of ~807 specific to the lipid A ion with an m/z of 1444, and, as mentioned 
above, an ion with an m/z of ~998 is specific to the lipid A ion with an m/z of 1580.  
In the structure shown in Figure 3-7, the NH2 group is not acylated, which is not 
very likely as the amide bonds are strong and not easily fragmented. But, most of the 
fragments are assigned based on the structure proposed. Also, it was shown in the 
literature1, 4 that the main difference between lipid A from B. pseudomallei KHW and B. 
thailandensis ATCC 700388 is the presence of the C14:0(2-OH) group. Such acyl chain 
could not be assigned in the structure proposed based on the MS/MS spectra collected.  
Figure 3-9 shows another hypothetical structure of the lipid A ion with an m/z 
value of 1580.040 which is isomeric to the structure shown earlier.  
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 Figure 3-9. Hypothetical structure of the parent molecule of the lipid A ion with 
                      an m/z value of 1580.040 
In the structure shown in Figure 3-9, it can be observed that an amide linked C16:0 
acyl chain is present. Also, a C14:0(2-OH) was incorporated in the structure. However, the 
major drawback with this structure was inability to assign most of the fragment ions.  
As mentioned previously, the lipid A ion, with an m/z value of 1580.040 might be 
a structural modification on lipid A ion with an m/z value of 1443.968 since the 
difference in masses between these two ions is ~136. However, a hypothetical structure 
with a structural modification on the lipid A ion with an m/z value of 1443.968 that 
results in the formation of a lipid A ion with an m/z value of 1580.040, could not be 
proposed based on acquired MALDI-MS/MS data. 
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3.2. MALDI-MS and MALDI MS/MS Analysis of O-deacylated Lipid A  
The research performed so far on lipid A from B. pseudomallei and B. 
thailandensis identified the fatty acid profiles,1, 4 but exact positions of acyl chains were 
not confirmed experimentally. To test the acyl chain composition of lipid A species from 
B. pseudomallei 1026b, the O-deacylation study of lipid A samples was performed. 
Partial and complete O-deacylation of lipid A was performed using ammonium 
hydroxide and methylamine, respectively. The complete deacylation removed all the ester 
linked acyl chains, both primary linked and secondary linked O-acyl chains. MALDI-MS 
spectra obtained after complete deacylation revealed the presence of ions with m/z values 
of 927.591 and 1007.548 (Figure 3-10). The partial deacylation was expected to remove 
primary ester-linked acyl chains located at positions 3 and 3′ of the lipid A disaccharide 
backbone.74 MALDI-MS spectra obtained after partial deacylation of B. pseudomallei 
1026b lipid A show ions with m/z values of 1137.712 and 1217.639 as the most intense 
peaks (Figure 3-13). MALDI-MS/MS experiments were performed on all four ions from 
partial and complete deacylation. 
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From the MS/MS data of the ion with an m/z of 927.591 (Figure 3-11), which is 
due to loss of all ester linked acyl chains from lipid A ion with an m/z of 1363.997, 
different fragment ions were assigned. The ions with m/z values of 614.765, 554.801 and 
312.911 were assigned as 0,2A2, 0,4A2, and 0,2X2 respectively. 
Figure 3-10: A MALDI-MS spectrum of lipid A from B. pseudomallei 1026b 
           acquired in negative ion mode using ATT as the matrix after     
          complete O-deacylation using methylamine. Inset: hypothetical 
          structure of the precursor of the ions with m/z 927.591 and    
          1007.548.  
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   Figure 3-11: A MALDI-MS/MS spectrum of ion with an m/z of 927.591 acquired  
                    in negative ion mode using ATT as the matrix after complete O-                 
                       deacylation using methylamine. Inset: hypothetical structure of the   
                       parent lipid A molecule 
A MALDI-MS/MS spectrum of the ion with an m/z of 1007.548 is shown in 
Figure 3-12. Loss of phosphate group from the deprotonated ion resulted in the formation 
of ion with an m/z value of 909.890. Different cross-ring fragments like 2,4X2-C16:0, 0,2A2-
H2O, and 0,4A2, were observed with m/z values of 694.386, 596.935, and 554.951 
respectively. 
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MALDI-MS data obtained after partial deacylation revealed the presence of three 
ions with m/z values of 1137.712, 1217.639, and 1268.708 (Figure 3-13). The ion with an 
m/z of 1137.712 likely corresponds to the deacylation loss of C14:0 acyl chain (Δm/z ~ 
227) bound by an ester linkage to the lipid A ion with an m/z value of 1363.988.   
Figure 3-12: A MALDI-MS/MS spectrum of ion with an m/z of 1007.548     
          acquired in negative ion mode using ATT as the matrix after            
          complete O-deacylation using methylamine. Inset: hypothetical 
         structure of the parent lipid A molecule 
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The ion with an m/z of 1217.639 likely corresponds to the deacylation loss of the C14:0 
acyl chain bound by an ester linkage to the lipid A ion with an m/z value of 1443.968.  
Also, the ion with an m/z value of 1268.708 corresponds to deacylation loss of two C14:0 
acyl chains bound by an ester linkage and loss of HPO3 to the lipid A ion with an m/z of 
1801.231.  
Figure 3-13: A MALDI-MS spectrum of lipid A from B. pseudomallei 1026b 
            acquired in negative ion mode using ATT as the matrix after partial 
            O-deacylation using NH4OH. Inset: hypothetical structures of the 
            precursor of the ions with m/z of 1137.712 and 1217.639 
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 A MALDI-MS/MS spectrum of ion with an m/z of 1137.712 is shown in Figure 3-
14. Loss of a C14:0 acyl chain from the parent ion resulted in an ion with an m/z of 
909.970.	  	  	  
	  
 
 
 
 
Two cross-ring fragments that are common were also seen in the spectra with m/z 
values of 825.007 (0,2A2) and 765.084 (0,4A2). The loss of C14:0 from 1137.712 is also 
confirmed by the ion with an m/z of 227.922. 
Figure 3-14: A MALDI-MS/MS spectrum of the ion with an m/z of 1137.712 
           acquired in negative ion mode using ATT as the matrix after            
           partial O-deacylation using NH4OH. Inset: hypothetical structure 
         of the parent lipid A molecule 
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MALDI-MS/MS spectra of the ion with an m/z of 1217.639 (Figure 3-15) 
revealed the presence of more cross-ring fragments. 0,4A2, 2,5A2, and 0,4A2, were the cross-
ring fragments seen with m/z values of 765.413, 807.381, and 825.376 respectively.  
 
 
 
 
 
Based on these cross-ring fragments from all MALDI-MS/MS data obtained after 
deacylation studies, positions of different acyl chains were confirmed and correspond to 
those shown by Novem et al. (Figure 1-7).1 By complete deacylation, a loss of C14:0(3-
OH) was noticed from the ion with an m/z of 1217, which is present as a secondary acyl 
Figure 3-15: A MALDI-MS/MS spectrum of the ion with an m/z of 1217.639 
           acquired in negative ion mode using ATT as the matrix after            
           partial O-deacylation using NH4OH. Inset: hypothetical structure 
          of the parent lipid A molecule 
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chain on an amide-link hexadecanoic acid C16:0. While the ion with an m/z of 1217 likely 
originates from partial O-deacylation of the ion with an m/z of 1444, it was not possible 
to detect any ion that would correspond to partial deacylation of the ion with an m/z of 
1580. Both ions with m/z of 1580 and 1444 may yield the same O-deacylation product 
(m/z 1217). This indicates that the structure with a mass of 136 is also cleaved during 
partial O-deacylation of lipid A ion with an m/z of 1580. While neutral loss of 136 was 
seen in lipids containing phosphatidic acid,77 it has not been possible to assign additional 
fragments in the MS/MS spectrum of the ion with an m/z of 1580 by adding phosphatidic 
acid to the lipid A ion with an m/z of 1444. 
 
3.3. ESI-MS, ESI-MS/MS, and ESI MS/MS/MS Analysis of Lipid A 
To further study the structure of the lipid A with an m/z of 1580, lipid A samples 
were analyzed using ESI-MS. In addition to analysis of ions with an ion trap mass 
spectrometer (data not shown), high-resolution ESI-MS spectra of lipid A from B. 
pseudomallei 1026b were acquired at Fred Hutchinson Cancer Research Center (Seattle, 
WA).  
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Peaks with m/z values of 789.509 (z=-2), 900.078 (z=-2), 1322.922 (z=-1), and 
1580.022 (z=-1) were the most intense in ESI-MS spectra (Figure 3-16). The ion with an 
m/z of ~1580 was detected as both a singly and doubly charged ion because it contains 
two phosphate groups.  
Figure 3-16: A high resolution ESI-MS spectrum of lipid A from B.              
          pseudomallei 1026b acquired in negative ion mode 
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MS/MS and MS/MS/MS analyses were done on singly charged peaks with an m/z 
of 1580 and 997, respectively. The most intense ion in MS/MS spectrum of ion with an 
m/z of 1580 (Figure 3-17) was an ion with an m/z of ~998, which was also detected by 
MALDI MS/MS. However, the ion with an m/z of 1444 was absent from the ESI- 
MS/MS spectrum. This is likely due to different modes of fragmentation in MALDI-MS 
and ESI-MS instruments (laser induced dissociation vs. high-energy collision-induced 
dissociation). The neutral loss of water from the ion with an m/z of 1580 was also 
Figure 3-17: A high resolution ESI-MS/MS spectrum of ion with m/z              
           1580.022 of lipid A from B. pseudomallei 1026b in negative ion 
           mode 
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observed. An MS/MS/MS spectrum of the ion with an m/z of 998 also indicated the 
neutral loss of water. However, no information on acyl chains was obtained by 
fragmentation of this ion (MS3 data not shown). 
 
 
  
 
 
Lipid A samples were also analyzed using Q-TOF-ESI-MS and ESI-MS/MS. MS 
analysis showed both singly (~1580) and doubly charged (~790) ions of the lipid A ion 
with an m/z of ~1580 (MS data not shown). MS/MS analysis indicated that there might be 
Figure 3-18: A Q-TOF-ESI-MS/MS spectrum of the ion with an m/z of     
          789.5062 of lipid A from B. pseudomallei 1026b in negative ion  
          mode 
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a possibility of C16:0 and/or C16:1 which are represented by m/z values of ~ 253 and ~ 255 
(Figure 3-18). 
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Chapter 4 
 
Conclusions and Future Work 
 
4.1 Conclusions 
Burkholderia pseudomallei is a virulent bacterium that can have lethal effects. 
Lipid A, which is a hydrophobic anchor of LPS, has been considered as the main reason 
for the endotoxic activity of the bacterium.11 The endotoxic activity of lipid A depends on 
the degree of acylation and phosphorylation.58 Structural analyses of lipid A helps in 
understanding the effects it has on the host’s defense system. Therefore, the MALDI-MS 
and ESI-MS results presented in this thesis are beneficial for studying the virulent 
properties of B. pseudomallei lipid A. 
 MALDI-MS and ESI-MS data revealed that the virulent B. pseudomallei and the 
avirulent B. thailandensis were different from each other as they have slightly different 
lipid A profiles. Novem et al.1 described that the difference was due to an additional 
hydroxyl group at position 2 on a C14:0 acyl chain located at position 3 on the disaccharide 
backbone. In this study it was found that there was another ion which was 
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different between B. pseudomallei 1026b and B. thailandensis E264. To account for this 
difference, a new structure was proposed with an additional C12:1 acyl chain to the 
structure that was proposed by Novem et al.1 There were other ions that were different 
between B. pseudomallei 1026b and B. thailandensis E264, but their intensities were very 
low and were not reproducible.  
For MALDI-MS analysis, matrices like ATT, DHB, and THAP were used to 
study the structures of lipid A from B. pseudomallei 1026b and B. thailandensis E264. In 
this investigation, ATT turned out to be the suitable matrix for lipid A samples. All the 
data shown for MALDI-MS and MALDI-MS/MS analysis were obtained in negative ion 
mode using ATT as the matrix. ESI-MS analysis was performed on a Thermo Orbitrap 
Elite, a Waters Q-TOF, and a Thermo Orbitrap Fusion. MALDI and ESI-MS data were 
similar except in the case of doubly charged ions that were formed by ESI but not 
produced using MALDI. However, there were some differences between MALDI and 
ESI MS/MS data due to different modes of fragmentation used.   
Upon analyzing all spectra, it has been concluded that a lipid A species with an 
m/z of 1580.040 (z=-1) is found in lipid A from B. pseudomallei 1026b. However, this 
ion was not observed by MS analysis of lipid A from B. thailandensis E264. The 
presence of two phosphoryl residues on the disaccharide backbone was confirmed by the 
peaks at m/z values of 97.623 and 159.783 in the MALDI-MS/MS spectrum of the lipid 
A ion with an m/z of 1580.040. This species might be a lipid A ion containing two 
phosphate groups and five acyl chains that are found in the lipid A ion with an m/z of 
1443.968. Two structures were proposed for the lipid A ion with an m/z value of 
1580.040. More fragments could be assigned using one structure (Figure 3-7, inset) that 
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has no acyl chain on the NH2 group located at position 2 on the disaccharide backbone. 
From the other structure (Figure 3-9), not many fragments ions were assigned, but it has 
an amide linked C16:0 acyl chain. The lipid A ion with an m/z value of 1580.040 could 
also be some kind of structural modification on lipid A ion with an m/z value of 
1443.968. This hypothesis is based on the similarities of MS/MS data of lipid A ion with 
an m/z of 1580.040 and lipid A ion with an m/z of 1443.968, and will need to be 
confirmed in future experiments.  
 To further confirm the structures of the lipid A ions seen in B. pseudomallei and 
B. thailandensis E264, deacylation studies were performed. Partial O-deacylation and 
complete O-deacylation experiments revealed important details about the acylation of 
lipid A molecules. MS/MS data helped in confirming the hypothetical structures of 
different lipid A species proposed by Novem et al.1 From the MS/MS data, different 
cross-ring fragments were assigned, which helped in confirming the structures. The 
positions of different acyl chains were confirmed from deacylation experiments and 
MS/MS experiments. However, the structure of the lipid A ion with an m/z of 1580.040 
has not been confirmed yet.  
 
4.2 Future Work 
Further analyses using techniques such as liquid chromatography-mass 
spectrometry (LC-MS) and nuclear magnetic resonance (NMR) spectroscopy are needed 
to determine the exact structure of the lipid A ion with an m/z of 1580.040. Ideally, a 
sufficient amount of lipid A with an m/z of 1580.040 should be collected using high 
performance liquid chromatography (HPLC) separation. If this is achieved, potential 
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toxic properties of this lipid A structure can be tested in live animal studies and its exact 
atomic structure can be determined by 2D NMR spectroscopy.11 
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 Separation of lipid A is considered to be a very difficult process because of its 
amphiphilic nature. However, methods were developed in the recent past to achieve 
successful separation of different lipid A species.1, 2 In this study, we tried to separate 
various lipid A species from B. pseudomallei 1026b. The primary goal of this study was 
to collect fractions of the lipid A species corresponding to an ion with an m/z value of 
1580.040, as this ion is not seen in a similar, but avirulent B. thailandensis E264 strain. 	  
 The separation process was carried out on a Shimadzu high performance liquid 
chromatography (HPLC) system coupled to Waters Q-TOF mass spectrometer. A C18 
column was used for the separation process. The mobile phases used and the gradient 
followed are shown in the Figure A-1.2 
 
  
Appendix A 
LC-MS study of lipid A from B. pseudomallei 1026b 
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 Lipid A sample was extracted using a mixture of chloroform, methanol, and 
water. 20 µL of sample in chloroform/methanol layer was injected into the HPLC system 
manually using a syringe. From the retention times on the C18 column, it can be said that 
the ion with an m/z value of 1580 is more polar in nature than the lipid A ions with m/z 
values of 1364 and 1801.   
 
 
                 
Figure A-1: An LC-MS chromatogram of lipid A from B. pseudomallei 
         1026b 
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 From the extracted ion chromatogram of the lipid A ion with an m/z value of 1364 
it can be seen that the retention time of this lipid A ion is between 35 and 40 minutes.  
 
 
 
 
 
 
  
Figure A-2: An extracted ion chromatogram of the lipid A ion with an m/z 
           of ~1364 from B. pseudomallei 1026b 
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 The mass spectrum obtained by integrating the extracted ion chromatogram 
(Figure A-2) is shown in Figure A-3. It is clearly seen that the peak at an m/z value of 
1363.8511 is the base peak. The singly and doubly charged ions with m/z values of 
1574.8873 and 786.9416 are also seen in the spectrum. The ion with an m/z of 1574.8873 
has an additional C14:0 acyl chain than the lipid A ion with an m/z value of 1363.8511, but 
they coelute together. 
 
   
 
 
   
Figure A-3: A mass spectrum of the lipid A ion with an m/z of          
         ~1364 from B. pseudomallei 1026b 
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 The extracted ion chromatogram of lipid A ion with an m/z value of 1580 is 
shown in the Figure A-5. From the figure, it is indicated that this lipid A ion is eluted out 
in the dead volume and also at a retention time of ~ 10-13 minutes.  
  
   
Figure A-4: An extracted ion chromatogram of the lipid A ion with an 
            m/z of ~1580 from B. pseudomallei 1026b 
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 The mass spectrum obtained by integrating the extracted ion chromatogram of the 
lipid A ion (Figure A-4) at a retention time window between 10 and 15 min is shown in 
Figure A-5. Singly and doubly charged ions with m/z values of 1579.9115 and 789.9486 
were observed. There are also peaks which might be due to the presence of impurities in 
the lipid A. 
 
   
Figure A-5: A mass spectrum of the lipid A ion with an m/z of                
         ~1580 from B. pseudomallei 1026b 
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 The extracted ion chromatogram for the lipid A ion with an m/z value of 1801 
(Figure A-6) indicated that this lipid A ion has two different retention times, one at ~15-
26 minutes and another at ~39-45 minutes. The peak at retention time of ~39-45 minutes 
was integrated to obtain the spectrum of the lipid A ion with an m/z value of 1801 (Figure 
A-7). 
 
 
 
   
Figure A-6: An extracted ion chromatogram of the lipid A ion with an m/z 
          of ~1801 from B. pseudomallei 1026b 
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 The singly and doubly charged ion of the lipid A ion were observed with m/z 
values of 1801.2502 and 900.0411 with the peak at m/z of 900.0411 being the base peak. 
A set of polymer peaks were also identified in the spectrum. As we use chloroform in our 
mobile phase, it likely deteriorates the peek tubing material, which is indicated by the 
presence of polymer peaks. 
 Further experiments should be done using a C8 column in order to obtain better 
separation of lipid A ions.2, 3 Such experiments should enable the HPLC purification and 
further structural characterization of unique lipid A species with an m/z of 1580.  
Figure A-7: A mass spectrum of lipid A ion with an m/z of ~1801 from 
         B. pseudomallei 1026b 
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